Skip to main content
Caplight Logo









Osler Diagnostics

Osler Diagnostics

Private
OxfordHealthcare & Life Scienceshttps://www.oslerdiagnostics.com/

Last Round

Series C

Nov 7, 2022

Est. Valuation

$88.54M

Total Funding Raised

$172M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Osler Diagnostics is a healthcare technology company that develops a portable diagnostic platform capable of providing lab-quality results from a single drop of blood.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

point-of-care diagnosticsPOC testingmedical deviceblood testingin-vitro diagnosticsIVDmicrofluidicselectrochemical biosensingdiagnostic hardwarerazor-and-blades modelclinical diagnosticsportable labtest cartridgesmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Osler Diagnostics Comparables

Compare Osler Diagnostics with similar companies based on industry and business-model similarity.

Osler Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vital Bio
86%
Truvian
85%
Proxim Diagnostics Corp.
78%

Osler Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CNov 7, 2022
Series BNov 20, 2020
Series ADec 20, 2018
SeedJul 1, 2016

Key People

Founding team and executive leadership

David Edington

CTO

Executive Team

Paul Dixon

Chief Financial Officer

Executive Team

Osler Diagnostics Investors

Notable investors and investment history

Osler Diagnostics investors
InvestorRounds
Braavos Investment AdvisersSeries C
Oxford Science EnterprisesSeries C, Series A, Series B, Seed
Oxford Technology Investment FundSeed
M&G InvestmentsSeries C
Lansdowne PartnersSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 250% MoM.

  • Jul 24, 2026

    Monthly visitors increased 311% MoM.

Osler Diagnostics Filings

Explore SEC and related filing metadata, where available.

Osler Diagnostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Osler Diagnostics's valuation, stock price, and market status.

Is Osler a public or private company?

Osler is a private company.

What is the current stock price of Osler?

Osler is a private company with no public stock price. No recent secondary market data is available.

How much is Osler worth (valuation)?

Osler's valuation is estimated at $88.5M based on funding round data.

Can I buy Osler stock?

Osler shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Osler's last funding round?

Osler's most recent funding round was Series C on December 20, 2018.

Who are the main investors in Osler?

Key investors in Osler include M&G Investments.

Will Osler IPO soon?

No public IPO plans have been announced for Osler.

How can I track Osler secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Osler's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOxford
Employee Range107
Year Founded2017
Last FundingNov 7, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?